BioSpace News Archive

Business

Arcadia Biosciences (RKDA) Announces Strong Third Quarter 2022 Financial Results and Business Highlights

Arcadia Biosciences, Inc.® (Nasdaq: RKDA), a producer and marketer of innovative, plant-based health and wellness products, today released its financial and business results for the third quarter of 2022.

November 10, 2022
·
7 min read
Business

Relmada Therapeutics Provides Corporate Update and Reports Third Quarter 2022 Financial Results

Relmada Therapeutics, Inc. today provided a corporate update and announced preliminary and unaudited financial results for the three and nine months ended September 30, 2022.

November 10, 2022
·
12 min read
Business

Histogen Reports Third Quarter 2022 Financial Results and Provides Business Update

Histogen Inc. (NASDAQ: HSTO) today reported financial results for the third quarter ended September 30, 2022 and provided an update on its clinical pipeline and other corporate developments.

November 10, 2022
·
10 min read
Business

Panbela Provides Business Update and Reports Q3 2022 Financial Results

Panbela Therapeutics, Inc. (Nasdaq: PBLA) , a clinical stage company developing disruptive therapeutics for the treatment of patients with urgent unmet medical needs, today provides a business update and reports financial results for the quarter ended September 30, 2022.

November 10, 2022
·
13 min read
Genetown

Yumanity Therapeutics Announces Effectiveness of Registration Statement on Form S-4 In Connection With Proposed Asset Sale to Janssen and Merger with Kineta, Inc.

Yumanity Therapeutics, Inc. announced that the registration statement on Form S-4, relating to the previously announced asset sale to Janssen Pharmaceutica NV and merger with Kineta, Inc., has been declared effective by the U.S. Securities and Exchange Commission.

November 10, 2022
·
12 min read
Genetown

Quanterix to Participate in the Canaccord MedTech, Diagnostics and Digital Health & Services Forum

Quanterix Corporation today announced that President and Chief Executive Officer Masoud Toloue and Chief Financial Officer Michael Doyle will present at the CG MedTech, Diagnostics and Digital Health & Services Forum on Thursday, November 17, 2022 at 4:30 p.m. EST in Boston, MA.

November 10, 2022
·
2 min read
Business

Molecular Templates, Inc. Reports Third Quarter 2022 Financial Results

Molecular Templates, Inc. (Nasdaq: MTEM, “Molecular Templates,” or “MTEM”) today reported financial results and business updates for the third quarter of 2022.

November 10, 2022
·
14 min read
Business

Danaher Launches Beacon Initiative and Its First Partnership Focused on Gene Therapy Innovation

Danaher Corporation, a global science and technology innovator, announced that it has entered a strategic partnership with Duke University to form its first Danaher Beacon for Gene Therapy Innovation.

November 10, 2022
·
3 min read
Biotech Beach

Tyra Biosciences to Present at Upcoming Investor Conferences

Tyra Biosciences, Inc. today announced that the Company will be presenting and hosting one-on-one meetings at the following conferences in November.

November 10, 2022
·
1 min read
Bio NC

Chimerix Responds to Rubric Capital Management

Chimerix issued the following statement regarding a press release issued by Rubric Capital Management:

November 10, 2022
·
3 min read